Trials / Completed
CompletedNCT01099488
A Study in Healthy Adults Having Received a Single Vaccine Administration to Support the Development of Immunological Assays
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to develop immunological assays on blood samples.
Detailed description
This is a clinical study in which there is no vaccine administered. It is designed for research purposes such as developing immunological assays.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood withdrawal | Healthy male or female adults between, and including, 18 and 50 years of age at the time of study start, having received GSK2231392A vaccine, were enrolled for blood withdrawal, at each study visit: Day 0, Day 14 and Day 180, to support the development of CD8+ T cell immunological detection assays. |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-12-07
- Completion
- 2010-12-07
- First posted
- 2010-04-07
- Last updated
- 2017-06-27
Locations
2 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01099488. Inclusion in this directory is not an endorsement.